ArticleBMC nutrition2025

Modification of metabolic syndrome parameters following the administration of polyglucosamine L112: results of a subgroup analysis of subjects enrolled in a double blind randomised placebo controlled clinical investigation.

Mariangela Rondanelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.